濟生

-0.15 (-0.52%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

28.809成交張數9.11本益比1.23股價淨值比4.51%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	20	14	31.2%	1.80	23.42	14.0%	9.8%	0.9	0.6
2026Q1	19	14	26.3%	2.26	23.98	13.1%	9.6%	0.0	-0.2
2025Q4	19	14	28.7%	2.01	23.08	12.4%	8.9%	1.0	0.8
2025Q3	19	13	29.9%	1.90	22.33	12.9%	9.1%	1.2	1.1
2025Q2	18	13	29.9%	1.84	22.66	11.3%	7.7%	0.2	0.1
2025Q1	18	13	26.3%	2.09	23.05	9.9%	7.1%	0.4	0.4
2024Q4	17	13	27.2%	2.10	22.37	8.9%	6.3%	0.7	0.5
2024Q3	17	12	28.4%	1.93	21.51	5.9%	4.1%	0.2	-0.0
2024Q2	18	12	32.6%	1.70	21.16	6.1%	4.1%	1.1	0.9
2024Q1	18	12	30.1%	1.86	21.80	5.9%	4.2%	0.2	-0.0
2023Q4	18	12	31.0%	1.78	21.39	5.6%	3.9%	0.3	0.1
2023Q3	18	12	30.7%	1.79	21.29	9.8%	6.7%	-0.2	-0.5
2023Q2	17	12	31.7%	1.73	20.94	12.3%	8.1%	0.2	0.1
2023Q1	17	12	28.4%	1.99	21.78	12.3%	8.6%	0.5	0.3
2022Q4	18	12	32.1%	1.78	21.45	13.3%	8.9%	0.6	0.4
2022Q3	17	12	32.7%	1.41	20.22	12.0%	8.0%	0.6	0.2
2022Q2	17	11	35.8%	1.37	19.30	9.9%	6.8%	0.5	0.5
2022Q1	17	11	32.2%	1.55	19.90	8.5%	6.0%	0.3	0.3
2021Q4	17	11	33.7%	1.46	19.32	7.4%	5.1%	0.7	0.6
2021Q3	16	11	33.9%	1.39	18.75	5.2%	3.6%	0.4	-1.8
2021Q2	15	11	26.5%	2.47	19.31	3.9%	2.8%	0.2	-0.1
2021Q1	15	11	26.1%	2.53	19.07	4.2%	3.0%	0.1	0.0
2020Q4	15	11	27.6%	2.34	18.88	5.5%	3.9%	0.5	0.5
2020Q3	15	11	26.8%	2.33	18.63	6.8%	4.9%	0.2	0.1
2020Q2	15	10	31.0%	1.95	18.41	7.6%	5.3%	0.3	0.2
2020Q1	15	11	29.0%	2.11	19.20	7.8%	5.6%	0.4	0.4
2019Q4	15	11	29.6%	2.02	18.81	6.8%	4.8%	0.4	0.3
2019Q3	15	11	29.1%	1.96	18.53	5.5%	3.8%	0.7	0.7
2019Q2	15	10	30.8%	1.79	18.42	5.5%	3.7%	0.6	0.5
2019Q1	15	11	28.6%	1.90	18.71	4.3%	3.1%	0.0	-0.1
2018Q4	15	10	30.5%	1.78	18.34	4.0%	2.8%	0.6	0.3
2018Q3	15	10	31.6%	1.72	18.16	5.0%	3.5%	0.2	0.0
2018Q2	15	10	33.0%	1.63	18.07	5.9%	4.0%	0.1	-0.0
2018Q1	15	11	30.4%	1.78	18.74	6.6%	4.6%	0.3	0.1
2017Q4	15	11	28.9%	1.83	18.49	7.9%	5.6%	0.4	0.3
2017Q3	15	10	30.4%	1.74	18.20	9.0%	6.3%	0.5	0.3
2017Q2	15	10	31.5%	1.64	17.72	8.9%	6.1%	0.3	0.3
2017Q1	15	10	31.0%	1.70	18.09	8.4%	5.8%	0.5	0.4
2016Q4	14	10	28.8%	1.72	17.90	–	–	0.3	0.1
2016Q3	14	10	29.9%	1.63	17.53	–	–	0.5	0.2